Published in Gastroenterology on November 06, 2008
Intestinal mucosal barrier function in health and disease. Nat Rev Immunol (2009) 7.15
Homeostasis and inflammation in the intestine. Cell (2010) 4.60
Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology (2011) 2.90
Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol (2011) 2.67
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol (2010) 2.58
ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell (2009) 2.10
Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut (2010) 1.92
Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (2015) 1.76
Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem (2010) 1.74
Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol (2010) 1.73
MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci U S A (2010) 1.70
Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity (2011) 1.53
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut (2011) 1.51
Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell (2010) 1.51
Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function. Dig Dis Sci (2015) 1.41
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol (2013) 1.41
Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier function. Dig Dis Sci (2012) 1.40
The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol (2009) 1.37
Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One (2009) 1.32
Latent cytomegalovirus infection exacerbates experimental colitis. Am J Pathol (2009) 1.30
Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology (2011) 1.28
Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology (2013) 1.24
The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol (2012) 1.22
Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol (2013) 1.21
Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci (2012) 1.19
Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier. PLoS One (2011) 1.17
Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J Physiol (2013) 1.12
Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci (2012) 1.12
Biochemistry of smooth muscle myosin light chain kinase. Arch Biochem Biophys (2011) 1.06
Mechanisms and functional implications of intestinal barrier defects. Dig Dis (2009) 1.04
Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol (2014) 1.03
Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood) (2014) 1.03
Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest (2012) 1.01
TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One (2011) 0.98
Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis. Oncogene (2011) 0.95
Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS One (2013) 0.95
Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. J Biol Chem (2011) 0.94
Fetal cholinergic anti-inflammatory pathway and necrotizing enterocolitis: the brain-gut connection begins in utero. Front Integr Neurosci (2013) 0.94
Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease. J Gastroenterol (2015) 0.93
IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis (2014) 0.92
Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation (2012) 0.92
TLR sorting by Rab11 endosomes maintains intestinal epithelial-microbial homeostasis. EMBO J (2014) 0.92
Enteric pathogens through life stages. Front Cell Infect Microbiol (2012) 0.91
Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol (2009) 0.91
Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol (2015) 0.91
Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel disease. Clin Transl Gastroenterol (2012) 0.90
Emerging neuropeptide targets in inflammation: NPY and VIP. Am J Physiol Gastrointest Liver Physiol (2013) 0.89
Basolateral Mg2+ extrusion via CNNM4 mediates transcellular Mg2+ transport across epithelia: a mouse model. PLoS Genet (2013) 0.89
Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo. J Interferon Cytokine Res (2012) 0.89
Transepithelial antigen delivery in the small intestine: different paths, different outcomes. Curr Opin Gastroenterol (2013) 0.89
Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol (2016) 0.87
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil (2015) 0.87
Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice. J Immunol (2011) 0.87
Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation. EMBO Mol Med (2012) 0.86
Regulation of 130-kDa smooth muscle myosin light chain kinase expression by an intronic CArG element. J Biol Chem (2013) 0.86
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis. J Immunol (2015) 0.85
Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract (2015) 0.85
Claudin-2-dependent paracellular channels are dynamically gated. Elife (2015) 0.85
Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice. Dig Dis Sci (2012) 0.85
Tight junction CLDN2 gene is a direct target of the vitamin D receptor. Sci Rep (2015) 0.85
Claudin-2 regulates colorectal inflammation via myosin light chain kinase-dependent signaling. Dig Dis Sci (2013) 0.84
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling. J Clin Invest (2012) 0.84
Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses. Pharmacol Res Perspect (2015) 0.84
The Microbiome Activates CD4 T-cell-mediated Immunity to Compensate for Increased Intestinal Permeability. Cell Mol Gastroenterol Hepatol (2017) 0.83
A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms. Pharm Res (2014) 0.83
Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells. Gut Pathog (2010) 0.83
Roles of the cellular prion protein in the regulation of cell-cell junctions and barrier function. Tissue Barriers (2013) 0.82
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Am J Physiol Gastrointest Liver Physiol (2015) 0.81
Helicobacter pylori CagA disrupts epithelial patterning by activating myosin light chain. PLoS One (2011) 0.81
Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci (2013) 0.80
Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol (2015) 0.80
Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut (2014) 0.80
Adherent-invasive Escherichia coli target the epithelial barrier. Gut Microbes (2010) 0.80
Nonmuscle Myosin IIA Regulates Intestinal Epithelial Barrier in vivo and Plays a Protective Role During Experimental Colitis. Sci Rep (2016) 0.79
Role of NADH: quinone oxidoreductase-1 in the tight junctions of colonic epithelial cells. BMB Rep (2014) 0.79
Modeling autism: a systems biology approach. J Clin Bioinforma (2012) 0.79
Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. Gastroenterology (2016) 0.79
Conceptual barriers to understanding physical barriers. Semin Cell Dev Biol (2015) 0.78
Modeling the intra- and extracellular cytokine signaling pathway under heat stroke in the liver. PLoS One (2013) 0.78
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 0.78
The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol (2016) 0.78
Mechanisms of Immune Signaling in Colitis-Associated Cancer. Cell Mol Gastroenterol Hepatol (2014) 0.77
Claudin proteins, outside-in signaling, and carcinogenesis. Pflugers Arch (2016) 0.76
Salvianolic Acid B Restored Impaired Barrier Function via Downregulation of MLCK by microRNA-1 in Rat Colitis Model. Front Pharmacol (2016) 0.76
Bin1: a new player in IBD barrier dysfunction. Dig Dis Sci (2012) 0.76
Beyond Ussing's chambers: contemporary thoughts on integration of transepithelial transport. Am J Physiol Cell Physiol (2015) 0.76
Claudin-3 and occludin tissue content in the glands of colonic mucosa with and without a fecal stream. J Mol Histol (2015) 0.75
Intravenous phage display identifies peptide sequences that target the burn-injured intestine. Peptides (2012) 0.75
Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates. Cell Biochem Funct (2016) 0.75
Niacin ameliorates ulcerative colitis via prostaglandin D2-mediated D prostanoid receptor 1 activation. EMBO Mol Med (2017) 0.75
The mucosal barrier at a glance. J Cell Sci (2017) 0.75
Intestinal barrier dysfunction in human necrotizing enterocolitis. J Pediatr Surg (2016) 0.75
Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells. Oncoimmunology (2017) 0.75
Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice. World J Gastrointest Pharmacol Ther (2015) 0.75
Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury. Sci Rep (2016) 0.75
Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 9.63
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol (2003) 5.94
Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med (1986) 4.18
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (1993) 3.42
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science (1995) 3.16
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest (2005) 3.15
Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol (1997) 3.07
In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol (1995) 2.95
A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest (2004) 2.75
Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology (1993) 2.75
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest (2006) 2.67
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology (2002) 2.66
Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci (2006) 2.59
Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology (1989) 2.55
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem (1999) 2.15
A comparative analysis of two models of colitis in rats. Gastroenterology (1992) 2.13
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest (2006) 2.00
The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med (2006) 1.96
Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis (1999) 1.88
Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology (1998) 1.79
The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol (2008) 1.75
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology (2000) 1.63
Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology (2008) 1.62
Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Am J Physiol Gastrointest Liver Physiol (2005) 1.53
Inflammatory bowel disease: is it really just another break in the wall? Gut (2007) 1.46
Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut (1992) 1.42
Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol (1994) 1.38
CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J Immunol (2005) 1.31
A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. Gastroenterology (2008) 1.28
Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology (1999) 1.27
Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol (1999) 1.22
Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice. Inflamm Bowel Dis (2008) 1.03
Noninvasive in vivo analysis of human small intestinal paracellular absorption: regulation by Na+-glucose cotransport. Dig Dis Sci (2000) 0.96
The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J Pediatr (1998) 0.95
Early activation of mucosal dendritic cells and macrophages in acute Campylobacter colitis and cholera: An in vivo study. J Gastroenterol Hepatol (2008) 0.83
Characterization of ileal dendritic cell distribution in a rat model of acute and chronic inflammation. Inflamm Bowel Dis (2006) 0.83
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
Coxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5. Cell Host Microbe (2007) 3.34
Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol (2005) 3.22
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest (2005) 3.15
Recognition of host immune activation by Pseudomonas aeruginosa. Science (2005) 2.84
Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol (2008) 2.84
A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest (2004) 2.75
Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest (2006) 2.67
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology (2002) 2.66
Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci (2006) 2.59
Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol (2010) 2.47
Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell (2005) 2.46
The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol (2008) 2.42
CD95 promotes tumour growth. Nature (2010) 2.42
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature (2012) 2.36
Molecular ordering of the initial signaling events of CD95. Mol Cell Biol (2002) 2.36
Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell (2005) 2.29
Epithelial barriers in homeostasis and disease. Annu Rev Pathol (2010) 2.28
Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet (2004) 2.23
Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci U S A (2007) 2.20
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest (2011) 2.14
Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest (2011) 2.09
Continuing attrition of physician-scientists (CAPS): a preventable syndrome? Gastroenterology (2012) 2.00
Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest (2006) 2.00
IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology (2006) 1.89
Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol (2008) 1.76
Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (2015) 1.76
Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem (2010) 1.74
Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest (2007) 1.72
MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci U S A (2010) 1.70
LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology (2007) 1.70
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67
A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J Biol Chem (2004) 1.64
Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest (2008) 1.64
Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog (2007) 1.60
Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J Biol Chem (2006) 1.59
Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol (2011) 1.58
Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology (2010) 1.57
Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem (2008) 1.55
The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology (2011) 1.54
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell (2010) 1.51
Unraveling the genetics of autoimmunity. Cell (2010) 1.51
PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci U S A (2008) 1.51
Characterization of epithelial cell shedding from human small intestine. Lab Invest (2006) 1.45
Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure. Gastroenterology (2005) 1.42
Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology (2008) 1.41
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol (2009) 1.40
The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol (2009) 1.37
Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol (2009) 1.34
Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest (2005) 1.32
Cancer stem cells in head and neck squamous cell carcinoma. J Oncol (2010) 1.31
CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J Immunol (2005) 1.31
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci U S A (2011) 1.31
Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol (2006) 1.30
Anti-inflammatory effects of phosphatidylcholine. J Biol Chem (2007) 1.29
High-molecular-weight polyethylene glycol prevents lethal sepsis due to intestinal Pseudomonas aeruginosa. Gastroenterology (2004) 1.28
Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice. J Lipid Res (2008) 1.28
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol (2006) 1.26
Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. Am J Physiol Gastrointest Liver Physiol (2004) 1.25
Time-resolved luminescence resonance energy transfer imaging of protein-protein interactions in living cells. Proc Natl Acad Sci U S A (2010) 1.24
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology (2013) 1.24
Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore-microtubule attachments. EMBO J (2010) 1.24
Akt2 phosphorylates ezrin to trigger NHE3 translocation and activation. J Biol Chem (2004) 1.22
Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol (2013) 1.21
Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells. Am J Physiol Cell Physiol (2011) 1.21
Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol (2013) 1.20